Loading insider details...
Latest Form 4 (Nov 5, 2026): Sale of 700 IDXX shares, $494.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 5, 2026 | IDEXX LABORATORIES INC /DE (IDXX) | Sale | 700 | $494.0K |
| May 14, 2026 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/Award | 525 | n/a |
| May 11, 2026 | IDEXX LABORATORIES INC /DE (IDXX) | Exercise/Conversion | 257 | n/a |
| May 14, 2025 | IDEXX LABORATORIES INC /DE (IDXX) | Exercise/Conversion | 1,404 | $345.1K |
| May 8, 2025 | IDEXX LABORATORIES INC /DE (IDXX) | Exercise/Conversion | 262 | n/a |
| May 8, 2024 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/Award | 609 | n/a |
| May 1, 2024 | GLYCOMIMETICS INC (GLYC) | Grant/Award | 40,000 | n/a |
| Apr 2, 2024 | GLYCOMIMETICS INC (GLYC) | Grant/Award | 5,209 | $15.6K |
| Feb 1, 2024 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/Award | 14 | $7.3K |
| Nov 1, 2023 | IDEXX LABORATORIES INC /DE (IDXX) | Grant/Award | 19 | $7.5K |